COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

An Innovative Treatment for Cervical Precancer (UH3) (UH3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03084081
Recruitment Status : Recruiting
First Posted : March 20, 2017
Last Update Posted : March 5, 2020
National Cancer Institute (NCI)
Basic Health International
CryoPen, Inc.
University of Southern California
Albert Einstein College of Medicine
Harvard School of Public Health
Instituto Salvadoreno del Seguro Social
Hospital Universitario San Ignacio
Medical College of Wisconsin
Shanxi Academy of Medical Sciences Shanxi Dayi Hospital
Information provided by (Responsible Party):
The Cleveland Clinic

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2021